Massachusetts Financial Services CO Alector, Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Alector, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 174,718 shares of ALEC stock, worth $324,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,718

Previous 112,920 54.73%

Holding current value

$324,975

Previous $512,000 59.18%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.34 - $6.58 $268,203 - $406,630	61,798 Added 54.73%	174,718 $815,000
Q2 2024 Aug 09, 2024	BUY	$4.19 - $6.23 $15,880 - $23,611	3,790 Added 3.47%	112,920 $512,000
Q1 2024 May 14, 2024	BUY	$5.69 - $8.08 $499,866 - $709,828	87,850 Added 412.83%	109,130 $656,000
Q4 2023 Feb 08, 2024	SELL	$3.77 - $8.39 $2,529 - $5,629	-671 Reduced 3.06%	21,280 $169,000
Q3 2023 Nov 08, 2023	SELL	$5.2 - $8.77 $4,373 - $7,375	-841 Reduced 3.69%	21,951 $142,000
Q2 2023 Aug 09, 2023	SELL	$5.86 - $7.93 $3,146 - $4,258	-537 Reduced 2.3%	22,792 $136,000
Q1 2023 May 10, 2023	SELL	$5.85 - $9.84 $317,467 - $533,997	-54,268 Reduced 69.94%	23,329 $144,000
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $262,616 - $364,533	-38,171 Reduced 32.97%	77,597 $716,000
Q3 2022 Nov 09, 2022	BUY	$8.19 - $13.2 $676,698 - $1.09 Million	82,625 Added 249.3%	115,768 $1.1 Million
Q2 2022 Aug 09, 2022	SELL	$7.65 - $14.24 $941,860 - $1.75 Million	-123,119 Reduced 78.79%	33,143 $337,000
Q1 2022 May 11, 2022	BUY	$13.02 - $20.78 $1.61 Million - $2.57 Million	123,489 Added 376.8%	156,262 $2.23 Million
Q4 2021 Feb 10, 2022	BUY	$19.35 - $25.54 $634,157 - $837,022	32,773 New	32,773 $677,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $154M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Alector, Inc. Transaction History